The eTRANSAFE project on translational safety assessment through integrative knowledge management: achievements and perspectives
| dc.contributor.author | Pognan, François | |
| dc.contributor.author | Centeno, Emilio | |
| dc.contributor.author | Furlong, Laura I., 1971- | |
| dc.contributor.author | Guney, Emre | |
| dc.contributor.author | Mayer, Miguel Ángel, 1960- | |
| dc.contributor.author | Pastor Maeso, Manuel | |
| dc.contributor.author | Piñero González, Janet, 1977- | |
| dc.contributor.author | Ramírez Anguita, Juan Manuel | |
| dc.contributor.author | Ronzano, Francesco | |
| dc.contributor.author | Saüch Pitarch, Josep | |
| dc.contributor.author | Sanz, Ferran | |
| dc.date.accessioned | 2021-04-12T07:07:24Z | |
| dc.date.available | 2021-04-12T07:07:24Z | |
| dc.date.issued | 2021 | |
| dc.description.abstract | eTRANSAFE is a research project funded within the Innovative Medicines Initiative (IMI), which aims at developing integrated databases and computational tools (the eTRANSAFE ToxHub) that support the translational safety assessment of new drugs by using legacy data provided by the pharmaceutical companies that participate in the project. The project objectives include the development of databases containing preclinical and clinical data, computational systems for translational analysis including tools for data query, analysis and visualization, as well as computational models to explain and predict drug safety events. | |
| dc.description.sponsorship | This research received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreements eTRANSAFE (777365). This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA companies in kind contribution. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Pognan F, Steger-Hartmann T, Díaz C, Blomberg N, Bringezu F, Briggs K et al. The eTRANSAFE project on translational safety assessment through integrative knowledge management: achievements and perspectives. Pharmaceuticals (Basel). 2021; 14(3):237. DOI: 10.3390/ph14030237 | |
| dc.identifier.doi | http://dx.doi.org/10.3390/ph14030237 | |
| dc.identifier.issn | 1424-8247 | |
| dc.identifier.uri | http://hdl.handle.net/10230/47087 | |
| dc.language.iso | eng | |
| dc.publisher | MDPI | |
| dc.relation.ispartof | Pharmaceuticals (Basel). 2021; 14(3):237 | |
| dc.relation.projectID | info:eu-repo/grantAgreement/EC/H2020/777365 | |
| dc.rights | © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). | |
| dc.rights.accessRights | info:eu-repo/semantics/openAccess | |
| dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | |
| dc.subject.keyword | Data mining | |
| dc.subject.keyword | Data sharing | |
| dc.subject.keyword | Drug safety | |
| dc.subject.keyword | Integrative knowledge management | |
| dc.subject.keyword | Predictive modelling | |
| dc.subject.keyword | Read across | |
| dc.subject.keyword | Toxicology | |
| dc.subject.keyword | Translational safety assessment | |
| dc.title | The eTRANSAFE project on translational safety assessment through integrative knowledge management: achievements and perspectives | |
| dc.type | info:eu-repo/semantics/article | |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
Files
Original bundle
1 - 1 of 1

